EN2 is a candidate oncogene in human breast cancer
- 20 June 2005
- journal article
- Published by Springer Nature in Oncogene
- Vol. 24 (46) , 6890-6901
Abstract
Only a few critical oncogenes have been identified in the more commonly occurring cases of sporadic breast cancer. We provide evidence that EN2 is ectopically expressed in a subset of human breast cancer and may have a causal role in mammary tumorigenesis. Nontumorigenic mammary cell lines engineered to ectopically express En-2 have a marked reduction in their cycling time, lose cell contact inhibition, become sensitive to 17-AAG treatment, fail to differentiate when exposed to lactogenic hormones and induce mammary tumors when transplanted into cleared mammary glands of syngeneic hosts. RNA interference studies suggest that EN2 expression is required for the maintenance of the transformed phenotype of a human breast tumor cell line.Keywords
This publication has 33 references indexed in Scilit:
- The rules of attractionNature, 2003
- Bmi-1 determines the proliferative capacity of normal and leukaemic stem cellsNature, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Focus on breast cancerCancer Cell, 2002
- c-Myc in breast cancer.Endocrine-Related Cancer, 2000
- Molecular genetics of breast cancer progressionSeminars in Cancer Biology, 1999
- Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1bThe EMBO Journal, 1998
- The biology of erbB-2/nue/HER-2 and its role in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female miceCell, 1988
- A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell lineCell, 1986